Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants
Parasite, 12 1 (2005) 3-8
Published online: 2005-03-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
(2024)
https://doi.org/10.1016/bs.apar.2024.07.002
A comprehensive and critical overview of schistosomiasis vaccine candidates
Aya Al-Naseri, Samar Al-Absi, Rashika El Ridi and Noha MahanaJournal of Parasitic Diseases 45 (2) 557 (2021)
https://doi.org/10.1007/s12639-021-01387-w
Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis
Ursula Panzner, Jean-Louis Excler, Jerome H. Kim, et al.Frontiers in Tropical Diseases 2 (2021)
https://doi.org/10.3389/fitd.2021.719369
Schistosoma Mansoni Antigen Sm-p80: Prophylactic Efficacy using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models
Weidong Zhang, Gul Ahmad, Adebayo J Molehin, et al.Journal of Investigative Medicine 66 (8) 1124 (2018)
https://doi.org/10.1136/jim-2018-000786
Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum
Po-Ching Cheng, Ching-Nan Lin, Shih-Yi Peng, et al.PLOS Neglected Tropical Diseases 10 (2) e0004459 (2016)
https://doi.org/10.1371/journal.pntd.0004459
Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?
Cristina Toscano Fonseca, Sergio Costa Oliveira and Clarice Carvalho AlvesFrontiers in Immunology 6 (2015)
https://doi.org/10.3389/fimmu.2015.00095
Structure–function analysis of apical membrane‐associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control
Chiuan Yee Leow, Charlene Willis, Andreas Hofmann and Malcolm K JonesBritish Journal of Pharmacology 172 (7) 1653 (2015)
https://doi.org/10.1111/bph.12898
Immuno-evasive tactics by schistosomes identify an effective allergy preventative
Qyana Griffith, YanMei Liang, Patrick Whitworth, et al.Experimental Parasitology 153 139 (2015)
https://doi.org/10.1016/j.exppara.2015.03.012
Complement plays a minimal role in Sm-p80-mediated protection againstSchistosoma mansoni
Souvik Karmakar, Weidong Zhang, Gul Ahmad, et al.Human Vaccines & Immunotherapeutics 10 (3) 640 (2014)
https://doi.org/10.4161/hv.27576
Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni
Workineh Torben, Gul Ahmad, Weidong Zhang, et al.Vaccine 30 (48) 6753 (2012)
https://doi.org/10.1016/j.vaccine.2012.09.026
357 (2012)
https://doi.org/10.1002/9783527652969.ch22
Enzymatic Shaving of the Tegument Surface of Live Schistosomes for Proteomic Analysis: A Rational Approach to Select Vaccine Candidates
William Castro-Borges, Adam Dowle, Rachel S. Curwen, et al.PLoS Neglected Tropical Diseases 5 (3) e993 (2011)
https://doi.org/10.1371/journal.pntd.0000993
Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates
Leonardo P. Farias, Cibele A. Tararam, Patricia A. Miyasato, et al.Parasitology Research 108 (1) 123 (2011)
https://doi.org/10.1007/s00436-010-2045-1
Preclinical Prophylactic Efficacy Testing of Sm-p80–Based Vaccine in a Nonhuman Primate Model of Schistosoma mansoni Infection and Immunoglobulin G and E Responses to Sm-p80 in Human Serum Samples From an Area Where Schistosomiasis Is Endemic
Gul Ahmad, Weidong Zhang, Workineh Torben, et al.The Journal of Infectious Diseases 204 (9) 1437 (2011)
https://doi.org/10.1093/infdis/jir545
Schistosomiasis vaccines
Afzal A. Siddiqui, Bilal A. Siddiqui and Lisa Ganley-LealHuman Vaccines 7 (11) 1192 (2011)
https://doi.org/10.4161/hv.7.11.17017
Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum)
Weidong Zhang, Gul Ahmad, Workineh Torben and Afzal A. SiddiquiActa Tropica 118 (2) 142 (2011)
https://doi.org/10.1016/j.actatropica.2011.01.010
Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice
Gul Ahmad, Weidong Zhang, Workineh Torben, Zahid Noor and Afzal A. SiddiquiInternational Journal of Infectious Diseases 14 (9) e781 (2010)
https://doi.org/10.1016/j.ijid.2010.02.2266
Important Helminth Infections in Southeast Asia: Diversity and Potential for Control and Elimination, Part B
Robert Bergquist and Sara LustigmanAdvances in Parasitology, Important Helminth Infections in Southeast Asia: Diversity and Potential for Control and Elimination, Part B 73 297 (2010)
https://doi.org/10.1016/S0065-308X(10)73010-4
Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection withSchistosoma mansoniin mouse
W. ZHANG, G. AHMAD, W. TORBEN and A. A. SIDDIQUIParasite Immunology 32 (4) 252 (2010)
https://doi.org/10.1111/j.1365-3024.2009.01181.x
Sm‐p80‐based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni
G. AHMAD, W. TORBEN, W. ZHANG, M. WYATT and A. A. SIDDIQUIParasite Immunology 31 (3) 156 (2009)
https://doi.org/10.1111/j.1365-3024.2008.01091.x
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine
Gul Ahmad, Weidong Zhang, Workineh Torben, et al.Parasitology Research 105 (6) (2009)
https://doi.org/10.1007/s00436-009-1646-z
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model
Gul Ahmad, Weidong Zhang, Workineh Torben, et al.Vaccine 27 (21) 2830 (2009)
https://doi.org/10.1016/j.vaccine.2009.02.096
Experimental vaccines in animal models for schistosomiasis
Afzal A. Siddiqui, Gul Ahmad, Raymond T. Damian and Ronald C. KennedyParasitology Research 102 (5) 825 (2008)
https://doi.org/10.1007/s00436-008-0887-6
Assessment of a DNA vaccine encoding an anchored-glycosylphosphatidylinositol tegumental antigen complexed to protamine sulphate on immunoprotection against murine schistosomiasis
Eduardo JM Nascimento, Rosa V Amorim, André Cavalcanti, et al.Memórias do Instituto Oswaldo Cruz 102 (1) 21 (2007)
https://doi.org/10.1590/S0074-02762007000100003
The Schistosoma bovis Sb14-3-3ζ recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice
M. Siles-Lucas, N. Uribe, J. López-Abán, et al.Vaccine 25 (41) 7217 (2007)
https://doi.org/10.1016/j.vaccine.2007.07.021